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ments occurred at the following time-points: CK MB 14 hrs, myoglobin 8 hrs, troponin-T and 
troponin-116 hrs. Only myoglobin fell to normal within 48 hrs. 
Conclusion. This is the first human study to track the time course of cardiac serum marker 
release following a MI when the precise timing of vessel closure was known. Our results are 
consistent with previous human studies of marker elevation after MI symptom onset. There- 
fore, symptom onset appears to be a reliable surrogate for vessel closure in an acute MI. 
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disease with 1500 to 2000 patient admissions per year. 
Methods: We retrospectively reviewed charts of patients with ICD-9 codes (International 
Classification of Disease, 9th Revision) for HIV disease and acute coronary syndromes 
at our hospital between January 1996 and December 2000. Fifty patients with either 
unstable angina or myocardial infarction were identified. This represented approximately 
0.6% of all HIV patient admissions during that time period. 
Results: Of the standard cardiovascular dsk factors, one or more were present in 88% of 
the patients and only 5 patients were recently using cocaine. Forty-five (90%) of the 
patients were men and the mean age was 49 + 9 years. The average duration since diag- 
nosis of HIV infection was 7.8 _+ 4.7 years, the average CD4 count was 426 + 290 x 103 
and twenty-nine (58%) were taking protease inhibitors. Forty-five (90%) underwent car- 
diac catheterization during admission and 40 had significant (>50% diameter stenosis) 
coronary artery disease (42% with 1-vessel disease). Patients with (n=21) or without pro- 
tease inhibitor (n=29) use were not significantly different in clinical, demographic or 
angiographic characteristics. Twenty-five (50%) underwent percutaneous coronary inter- 
vention and 9 (18%) other patients had a coronary artery bypass graft surgery with an 
overall in-hospital mortality of 2.9% (0% in percutaneous coronary intervention). 
Conclusion: In a large population of patients with HIV disease, admission for acute cor- 
onary syndromes is uncommon. This descriptive study indicates that nearly all have one 
or more traditional risk factors. Peroutaneous coronary intervention or coronary artery 
bypass graft surgery cna be done safely with a low in-hospital mortality. Controlled, pro- 
spective data are required to assess if there is any direct association between HIV dis- 
ease and acute coronary syndromes. 
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ORAL  CONTRIBUTIONS 
840 Etiological Entit ies as Predictors of Risk 
in Acute  Coronary Syndromes 
Tuesday, March 19, 2002, 8:30 a.m.-lO:O0 a.m. 
Georgia World Congress Center, Hall D1 
8:30 a.m. 
840-1 Nonwhite Race Is Associated With a Higher Rate of 
Death and Ischemic Complications in Patients With 
Acute Coronary Syndromes Despite Modern Early 
Invasive Treatment 
Marc S. Sabatine. Gavin J. Blake, Mark H. Drazner, David A. Morrow, Laura A. 
Demopoulos, Peter M. DiBattiste, Carolyn H. McCabe, Christopher P. Cannon, Eugene 
Braunwald, Brigham and Women's Hospital Boston, Massachusetts. 
Background: In administrative databases and registries, nonwhite patients have been 
shown to be less likely to undergo invasive procedures and to have higher rates of 
adverse cardiac events. We sought to determine the association between race and out- 
come in patients with UNNSTEMI receiving modern therapy in a clinicai trial. 
Methods & Results: Of 2220 patients in TACTICS-TIM118, 498 were nonwhite (22.4%). 
Alt patients received aspirin, heparin, and upstream tirofiban and were randomized to 
invasive (INV) vs. conservative (CONS) management. In a Cox proportional hazards 
model that adjusted for confounders (including age, sex, cardiac risk factors, prior car- 
diac disease, ST deviation, and treponin elevation), nonwhite patients were at signifi- 
cantly increased risk for the composite endpoint of death, MI, or rehospitalization for ACS 
[hazard ratio (HR) 1.34, p=0.026]. When stratified by randomized treatment assignment, 
in the CONS arm there was no difference in outcome (HR for nonwhite patients 1.14, 
p=0.5), but in the INV arm nonwhite patients were at significantly higher risk (HR=1.70, 
p=0.005). Inclusion of angiographic extent of CAD and LVEF into the Cox model for 
patients in the INV arm did not diminish the increased risk associated with nonwhite race 
(HR=1.88, p=0.006), 
Conclusion: In UNNSTEMI, nonwhite patients assigned to invasive therapy are at sig- 
nificantly higher risk for death and ischemic complications. The reasons for this disparity 
are unclear and warrant further exploration. 
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840-2 HIV Disease and Acute Coronary Syndromes 
Randv B. Gould, Nioole B. Pearlstein, Mary C. De Voe, John T. Coppola, Frederick P. 
Siega[, John A. Ambrose, Saint Vincent Catholic Medical Centers of New York - 
Manhattan Division, New York, New York. 
Background: Sporadic cases have been reported of the association between HIV dis- 
ease and acute myocardial infarction. There are no large series and the response to 
interventional techniques is unknown. Our hospital center is a large referral base for HIV 
840-3 Benef i t  o f  Invasive Strategy for Women With Acute 
Coronary Syndromes: Observations From the TACTICS- 
TIMI 18 Trial 
Ruchira Glaser, Howard C. Herrmann, Sabina A. Murphy, Laura A. Demopoulos, Peter 
M. DiBattiste, Christopher P. Cannon, Eugene Braunwald, University of Pennsylvania 
Medical Center, Philade/phia, Pennsylvania, Brigham and Women's Hospital, Boston, 
Massachusetts. 
Background: Women with acute coronary syndromes (ACS) in the FRISC II trial had a 
worse outcome with invasive (INV) versus conservative (CON) management. However, 
this and other studies of management in ACS were performed before widespread use of 
glycopretein lib/Ilia inhibitors and stents. 
Methods: We compared the baseline characteristics and primary endpoint (death, MI, 
rehospitalization for ACS by 6 months) of 757 women and 1463 men treated with 
tirofiban and randomized to INV versus CON strategy in the TACTICS-TIM118 study. 
Results: Women were older, smoked less, and had less prior MI and coronary artery 
bypass grafting (CABG). Women presented less often with elevated cardiac markers, but 
there was no difference between men and women in TIMI risk score. Angiography and 
intervention rates were similar, but women had less severe CAD, including no critical 
lesions in 17% vs 9% of men (p<0.001). CABG rates were lower in women(15% vs 22% 
of men, p=0.003), but 30-day surgical mortality rates were similar. Finally, women and 
men had similar benefit from an early INV strategy (interaction p for gender = 0.6). The 
benefit was greatest in women with elevated troponin (primary endpoint of 18.6% vs 
29.0% in INV and CON arms, respectively, p=0.03) (see figure). 
Conclusions: Women with ACS had more risk factors than men and similar TIMI risk 
scores, but had less severe CAD. The benefit of tirofiban combined with an early INV 
strategy was similar in women and men, and enhanced in women presenting with ele- 
vated troponin T levels. 
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840-4 Dramatic Increase in 30-Day Morta l i ty  in Diabetic 
Patients With Non-ST Segment Elevation Acute 
Coronary Syndromes 
Marco Roffi. Leslie Cho, Deepak L Bhatt, Jennifer A. White, David J. Molitemo, Robed 
A. Harringtoo, Eric J. Topoi, The Cleveland Clinic Foundation, Cleveland, Ohio, Duke 
Clinical Research Institute, Durham, North Carolina. 
Background: Limited data. are available on outcome of diabetic patients presenting with 
non-ST-segment elevation acute coronary syndromes. Methods: We performed a 
pooled analysis of 4 glycoprotein nb/llla inhibitor-acute coronary syndrome tnals, PARA- 
GON A, PARAGON B, PURSUIT, and GUSTO IV, and addressed the impact of diabetes 
on 30-day mortality. Results: The Kaplan-Meier curves for 30-day mortality in diabetics 
and nondiabetics are shown in the Figure. Multivariate analysis demonstrated that diabe- 
tes was an independent predictor of mortality in the overall study population (hazard ratio 
1 38, p<0.001). Subgroup analysis among diabetic patients demonstrated following 30- 
day mortality rates: 7.7% for age >65 years vs. 2.7% for age ~ 65 years (p<0.001); 6.5% 
for insulin-dependent vs. 5.1% for non-insulin-dependent (p<0.037); 12.6% for creatinine 
>1.5 mg/dt vs. 4.8% for croatinine _< 1.5 rag/all (p<0.001). In a multivariate regression 
model, reduced renal function, ST-segment depression on ECG, insulin dependent dia- 
betes, and history of congestive heart failure, were all significant independent predictors 
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of 30-day mortality among diabetics. Conclualone: Despite the contemporary manage- 
ment, diabetic patients wffh non-ST-segment elevation acute coronary syndromes have 
almost doubled 30-day mortality than nondiabetica. 
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840-5 In-Hospital Outcome of Acute Myocardial Infarction in 
Patients With Prior Coronary Artery Bypass Surgery: A 
Study From NRMI 3 
Verahese Mathew. Bernard J. Gersh, Hal Barren, Nathan Every, Alan T~efenbrunn, Paul 
Frederick, Judith Malmgren, For the NRMI Investigators, Mayo Clinic and Foundation, 
Rochester, Minnesota. 
Background: Patients with coronary artery bypass grafting (CABG) comprise an increas- 
ing proportion of acute myocardial infarction (MI) patients. Data regarding the influence 
of prior CABG on survival after MI is discordant; the influence of sinus tachycardia (ST) 
segment shift (ST elevation vs non-ST elevation) on outcome has not been examined in 
this population. We sought to describe the characteristics of patients with and without 
prior CABG presenting with acute MI, with or without ST segment elevation/left bundle 
branch block (LBBB), and to evaluate the effect of ST segment shift on in-hospital mortal- 
ity in patients with prior CABG. 
Methods: Utilizing the NRMI-3 Registry, we identified 112,697 patients with acute Mt with- 
out exclusion criteria. Of these, 15,936 (14.t%) had prior CABG. 
Results: Patients with prior CABG had more adverse baseline characteristics, and were 
less likely to present with ST elevation/LBBB than patients without prior CABG. The 
unadjusted mortality for ST elevation/LBBB patients was higher in patients with prior 
CABG compared to those without (16.2% vs 14.1%, P=0.0001) whereas in patients with- 
out ST elevation/LBBB, prior CASG patients had a lower unadjusted mortality than 
patients without prior CABG (10.1% vs 12.4%, P=0.0001). Adjusting for baseline differ- 
ences, prior CABG was weakly associated with in-hospital mortality in patients present- 
ing with ST elevation/LBBB (odds ratio (OR), 1.11, 96% confidence intervals (CI) 1.00- 
1.23), whereas prior CABG did not correlate with in-hospital mortality in patients present- 
ing without ST elevation/LBSB (OR 0.99, 96% CI 0.92-1.07). 
Conclusion: Patients with prior CABG who present with acute MI are more likely to 
present without ST etevation/LBBB, as compared to patients without phor CABG. Prior 
CABG was weakly associated with in-hospital mortality in patients with ST elevation/ 
LBBB, but did not influence in-hospital mortality in patients without these electrocardio- 
graphic findings. This suggests the difference in absolute mortality rates between 
patients presenting with MI with and without a history of prior CABG are in large part due 
to differences in baseline characteristics, 
9:45 a.rn. 
840-6 Cardiovascular Manifestations of Carbon Monoxide 
Poisoning 
Daniel Satran. Christopher R. Henry, Caren I. Chaney, Cheryl D. Adkinson, Timothy D. 
Henry, Hennepin County Medical Center, Minneapolis, Minnesota, University of 
Minnesota, Minneapolis, Minnesota. 
Carbon monoxide (CO) poisoning is a common cause of morbidity and mortality. While 
the neurologic sequelae of CO poisoning have been described, the cardiovascular com- 
plications are limited to isolated case reports. Methods: We reviewed the cardiovascular 
manifestations of 216 consecutive patients(Pts) treated for severe CO poisoning in the 
hyperbaric oxygen chamber at Hennepin County Medical Center, a regional center for 
treatment of CO poisoning. Results: The mean age was 47.2 years. 35 (16.4%) Pts had a 
normal baseline EKG; 94 (44.1%) sinus tachycardia; 85 (39.9%) non-specific ST 
changes; 63 (29.6%) ischemic changes, including 53 (24.8%) with dynamic ST or T wave 
changes and 10 (4.7%) with ST elevation. Of the 171 pts with cardiac enzymes, 75 
(34.7% of the total) were diagnostic of myocardial injury (CK-MB mass >5.0 ng/ml or 
troponin I >0.7 ng/ml). An additional 4 pts had EKG changes diagnostic of myocardial 
injury, but without cardiac enzymes. Of the 49 pts with echocardiograms, 27 (55.1%) had 
decreased left ventricular (LV) function. Of those 27, 14 had global wall motion abnormal- 
ity (WMA), and 13 had regional WMA. An additional 16 had RV dysfunction. In hospital 
mortality was only 3.7% (n=8), the most common cause being anoxic brain and burn 
injury (n=5). 3 Pts had an out of hospital cardiac arrest leading to anoxic brain injury and 
death. Two clear patterns of myocardial injury were identified. Older Pts with cardiac risk 
factors or previous CAD were more likely to have regional WMA with myocardial injury 
related to CAD. In contrast, another group was younger, without evidence of CAD, and 
more likely to have reversible global LV dysfunction. Conclusions: This is the first system- 
atic description of cardiovascular manifestations of CO poisoning. Cardiovascular 
sequelae of severe CO poisoning are frequent (36.6% with myocardial injury) and often 
unrecognized but mortality is related to noncardiac causes. Pts admitted with severe CO 
poisoning should have a baseline EKG and serial cardiac enzymes. Pts with EKG 
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changes or elevated enzymes should have an echocardiogram. Pts with myocardial 
injury in association with cardiac risk factors, previous CAD or persistent LV dysfunction 
deserve further evaluation. 
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841-1 Outcome After Acute Myocardial Infarction In Young 
Patients: Analysis of the PAMI Database 
Roberto A. Comus. Jr., Judith A. Boura, Gregg W. Stone, Bruce R. Brodie, David A. Cox, 
Eulogio Garcia, Lori L Grines, William W. O'Neill, Cindy L. Grines, William Beaumont 
Hospital, Royal Oak, Michigan. 
Background: Acute myocardial infarction (AMI) in patients (pts) < 40 years old (y/o) is 
uncommon. Few data exist regarding the outcome of these pts after percutaneous inter- 
vention (PCI) for AMI. 
Methods: This analysis pooled pts from 7 PAMI studies for a total of 4017 pts. Pts < 40 y/ 
o (N=171) were compared to pts > 40 y/o (N=3846). In-hospital, 6 month and 1 year out- 
comes are reported. 
Results: Younger pts were more often male and had a significantly higher incidence of 
smoking and family history of CAD, but a lower incidence of hypertension, diabetes, 
stroke, and prior coronary intervention compared to pts > 40 y/o. Younger pts had larger 
infarct sizes as measured by peak CPK (2974 vs. 2016, p=0.003) but no significant differ- 
ence in ejection fraction at baseline (50% vs. 48%) or 6 months (54% vs. 55%) compared 
to older pts. Younger pts had less muitivessel disease (p<0.001) and greater achieve- 
ment of TIMI 3 flow (99% vs. 92%, p=0.006) after PCI. While pts < 40 y/o had less mor- 
tality compared to older pts, recurrent AMI was significantly higher in the younger 
population (p=0.012). 
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In multivariate analysis, age _< 40 was the most significant predictor of re-infarction at 1 
year (OR=3.62 [95%C1: 1.794-7.296], p=0.0003. 
Conclusions: While pts _< 40 years old have improved survival after AMI, they have an 
increased rate of nonfatal re-infarction at 1 year compared to older pts. These data sug- 
gest the need for comprehensive diagnostic evaluation, aggressive nsk factor modifica- 
tion, and intensive follow-up in young pts with AMI. 
8:45 a.m. 
841-2 Interleukln-1 Beta Predicts Death or Myocardial 
Infarction Independently of High-Sensitivity C-Reactive 
Protein and Standard Risk Factors in Patients With 
Coronary Artery Disease 
Jason M. Laooe'. Joseph B. Muhlestein, John F. Cadquist, Brent P. Davis, Benjamin D. 
Home, Jeffrey L. Anderson, LDS Hospital, Salt Lake City Utah, University of Utah, Salt 
Lake City, Utah. 
Background: Intarleukin (IL)-I beta, tumor necrosis factor alpha (TNFalpha) and IL-6 
are important proinflammatory cytokines. IL-6 is produced in response to ~L-1 and TNFal- 
pha and is one of the major inducers of C-reactive protein (CRP). Elevated high-sensitiv- 
ity (hs)CRP is associated with an increased risk of death and MI in patients with 
CAD.The objective of this study was to determine whether IL-1, IL-6 or TNFalpha also 
independently predict death or MI in CAD patients. 
Methods: A nested case control study evaluating levels of IL-1 beta, IL-6, TNFalpha, and 
hsCRP (measured on the automated DPC Immulita platform) in 334 patients with signifi- 
cant, angiographically-proven coronary artery disease (>1 lesion of ->70% stenosis) was 
performed. Overall, 167 patients died or had an MI (cases), and 167 patients were event- 
free (controls). Cases were matched 1:1 to controls by age, gender, and time period of 
angiogram. Other cardiovascular hsk factors were recorded and patients followed for 
3.6~O.75 years (range: 2.0-5.0 years). 
Results: Average age was 69.6+9.9 years and 74% of patients were male. In multivad- 
able Cox regression controlling for 11 co-variables, hsCRP (hazard ratio [HR]= 1.24 per 
tertile, 95% confidence interval [CI]= 1.02-1.5, p=0.03) and IL-1 beta (HR=1.32 per tartile, 
CI= 1.08-1.6, p=0.008) were independently predictive of deatWIVll, but IL-6 (p=0.36, 
tracked with hsCRP) and TNFalpha (p=0.97) did not predict events. IL-6 and hsCRP 
were mildly correlated (r=0.38) and IL-1 beta nominally correlated with TNFalpha 
(r=0.24). No cytokine nor hsCRP was correlated with cholestarol evels. When analyzed 
jointly, having a high hsCRP (tertile 2,3) and high IL-1 beta (tertile 3) predicted a marked 
increase in events (HR=5.3, p<0.001) compared to low hsCRP (tertile 1) and low IL-1 
beta (tertile 1). 
